completely agree with what TheAnalyst said, 2RT is certainly exciting but iTrack advance is the main play atm. Whilst 2RT is some time away there should be some pretty major announcements (partnership, clinical trial info etc) this year which could result in 2RT having an actual positive impact on the share price, but for now we should be focused on iTrack advance as the certainty around that and the incredible potential of it in a super fast growing market is the main reason for this stock being so undervalued
Nova Eye Medical (EYE) Discussion, page-39
-
- There are more pages in this discussion • 3,149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.64M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $65.26K | 412.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 76733 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 239407 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |